Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: An open-label, nonrandomized chart review
- 1 October 2002
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 24 (10) , 1576-1584
- https://doi.org/10.1016/s0149-2918(02)80061-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Nonadherence With Mood StabilizersThe Journal of Clinical Psychiatry, 2002
- Correlates of Overweight and Obesity in 644 Patients With Bipolar DisorderThe Journal of Clinical Psychiatry, 2002
- Obesity and Medical Illnesses in Psychiatric Patients Admitted to a Long-term Psychiatric FacilityJournal of Psychiatric Practice, 2001
- A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I DisorderArchives of General Psychiatry, 2000
- Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelinesAmerican Journal of Psychiatry, 1996
- Obesity and endocrine disorders in women taking valproate for epilepsyAnnals of Neurology, 1996
- Bodyweight Change as an Adverse Effect of Drug TreatmentDrug Safety, 1996
- Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study GroupPublished by American Medical Association (AMA) ,1994
- Lithium and Weight GainInternational Clinical Psychopharmacology, 1990
- Prospective studies on a lithium cohortActa Psychiatrica Scandinavica, 1988